TG Therapeutics, Inc. (TGTX) stock
TGTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/303% above fair value
$66.12+3.41 (+5.44%)
Close on Nov 18, 2026Market cap $10.12BP/E 24.1Yield –
TG Therapeutics cash
Cash and short-term investments held at the end of each period.
TG Therapeutics's cash was $612.30M at Jun 30, 2026. For fiscal 2025 it was $199.50M, down 35.9% from the year before. Over ten years it grew 6.9% a year on average. The highest annual figure on record is $605.40M in fiscal 2020.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $199.50M | -35.9% |
| FY2024 | Dec 31, 2024 | $311.00M | +43.0% |
| FY2023 | Dec 31, 2023 | $217.50M | +24.9% |
| FY2022 | Dec 31, 2022 | $174.10M | -50.3% |
| FY2021 | Dec 31, 2021 | $350.30M | -42.1% |
| FY2020 | Dec 31, 2020 | $605.40M | +331.2% |
| FY2019 | Dec 31, 2019 | $140.40M | +100.2% |
| FY2018 | Dec 31, 2018 | $70.14M | -17.8% |
| FY2017 | Dec 31, 2017 | $85.30M | +87.6% |
| FY2016 | Dec 31, 2016 | $45.47M | -55.6% |
| FY2015 | Dec 31, 2015 | $102.40M | +29.8% |
| FY2014 | Dec 31, 2014 | $78.86M | +73.6% |
| FY2013 | Dec 31, 2013 | $45.43M | +176.1% |
| FY2012 | Dec 31, 2012 | $16.46M | +68.8% |
| FY2011 | Dec 31, 2011 | $9.75M | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $612.30M | +119.5% |
| Q1 FY2026 | Mar 31, 2026 | $572.80M | +107.4% |
| Q4 FY2025 | Dec 31, 2025 | $199.50M | -35.9% |
| Q3 FY2025 | Sep 30, 2025 | $178.30M | -47.7% |
| Q2 FY2025 | Jun 30, 2025 | $278.90M | +28.3% |
| Q1 FY2025 | Mar 31, 2025 | $276.20M | +31.6% |
| Q4 FY2024 | Dec 31, 2024 | $311.00M | +43.0% |
| Q3 FY2024 | Sep 30, 2024 | $341.00M | +48.8% |
| Q2 FY2024 | Jun 30, 2024 | $217.30M | +50.0% |
| Q1 FY2024 | Mar 31, 2024 | $209.80M | +50.2% |
| Q4 FY2023 | Dec 31, 2023 | $217.50M | +24.9% |
| Q3 FY2023 | Sep 30, 2023 | $229.20M | +15.9% |
| Q2 FY2023 | Jun 30, 2023 | $144.91M | -37.5% |
| Q1 FY2023 | Mar 31, 2023 | $139.70M | -50.2% |
| Q4 FY2022 | Dec 31, 2022 | $174.10M | -50.3% |
| Q3 FY2022 | Sep 30, 2022 | $197.70M | -48.2% |
| Q2 FY2022 | Jun 30, 2022 | $231.80M | -49.2% |
| Q1 FY2022 | Mar 31, 2022 | $280.70M | -46.4% |
| Q4 FY2021 | Dec 31, 2021 | $350.30M | -42.1% |
| Q3 FY2021 | Sep 30, 2021 | $381.40M | +50.0% |
| Q2 FY2021 | Jun 30, 2021 | $456.20M | +65.5% |
| Q1 FY2021 | Mar 31, 2021 | $523.80M | +569.0% |
| Q4 FY2020 | Dec 31, 2020 | $605.40M | +331.2% |
| Q3 FY2020 | Sep 30, 2020 | $254.20M | +250.9% |
| Q2 FY2020 | Jun 30, 2020 | $275.60M | +224.3% |
| Q1 FY2020 | Mar 31, 2020 | $78.30M | -15.3% |
| Q4 FY2019 | Dec 31, 2019 | $140.40M | +100.2% |
| Q3 FY2019 | Sep 30, 2019 | $72.45M | -25.9% |
| Q2 FY2019 | Jun 30, 2019 | $84.98M | -32.7% |
| Q1 FY2019 | Mar 31, 2019 | $92.47M | -15.3% |
| Q4 FY2018 | Dec 31, 2018 | $70.14M | -17.8% |
| Q3 FY2018 | Sep 30, 2018 | $97.74M | +6.5% |
| Q2 FY2018 | Jun 30, 2018 | $126.25M | +45.9% |
| Q1 FY2018 | Mar 31, 2018 | $109.20M | -0.3% |
| Q4 FY2017 | Dec 31, 2017 | $85.30M | +87.6% |
| Q3 FY2017 | Sep 30, 2017 | $91.80M | +51.2% |
| Q2 FY2017 | Jun 30, 2017 | $86.50M | – |
| Q1 FY2017 | Mar 31, 2017 | $109.50M | – |
| Q4 FY2016 | Dec 31, 2016 | $45.47M | – |
| Q3 FY2016 | Sep 30, 2016 | $60.70M | – |
See a number that looks wrong?